Phytopharm PLC
14 December 2007
Phytopharm plc
14 December 2007
DIRECTOR/PDMR SHAREHOLDING - Purchase of Ordinary Shares (the 'Shares') in
Phytopharm plc (the 'Company') by Directors of the Company under its employee
Share Incentive Plan (the 'SIP').
The SIP trustee, Equiniti Share Plan Trustees Limited (the 'Trustee'), notified
the Company on 12 December 2007 that the following Directors of the Company
acquired Shares under the SIP on 7 December 2007, in each case, held by the
Trustee:
Director Number of Aggregate number of Shares held beneficially
Shares acquired* following acquisition (across all accounts)
Daryl Rees 782 20,445
Piers Morgan 782 20,445
*The number of Shares acquired includes 391 Partnership Shares purchased by each
of these Directors at 32 pence and 391 Matching Shares issued to each of these
Directors under a Block Listing arrangement. Both partnership and matching
elements are registered in the name of the Trustee.
The SIP operates as follows:
Each month the Trustee uses participants' contributions (which may not exceed
£125 per participant per month) to purchase shares in the market. These shares
are called 'Partnership Shares'.
At the same time the Company allots to participants via the Trustee one
'Matching Share' for every Partnership Share purchased that month. These
Matching Shares vest with the employee three years from the date of issue.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.